Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Not losing weight on Ozempic® or Wegovy®? What to check

K
By Kelly Miller·August 26, 2026
Fact-checked
9 min read

Not losing weight on GLP-1 medicine can feel discouraging, even when you are doing everything right.

You may hear big numbers about Ozempic® or Wegovy® and wonder why your scale looks stuck. That is a common feeling, and it does not mean something is wrong with you.

This guide walks through common reasons weight change can slow, using facts from the branded trials. It also covers what to bring up with your prescriber.

Important safety information. Ozempic® and Wegovy® (both semaglutide) carry a boxed warning for thyroid C-cell tumors. In rodents, semaglutide caused these tumors, and it is not known whether it causes them, including medullary thyroid carcinoma (MTC), in people. Do not use either medicine if you or your family have a history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Key takeaways

  • Weight change on Ozempic® or Wegovy® can vary from person to person.
  • In Wegovy®'s STEP 1 trial, weight came off gradually across 68 weeks, not overnight.
  • Ozempic® is approved for type 2 diabetes; Wegovy® is approved for weight management.
  • The dose is stepped up slowly, so the early weeks may show little change.
  • Plateaus can be normal, so talk with your prescriber about your progress.

What this guide answers

  • Is it normal to not be losing weight on GLP-1 medicine yet?
  • What common reasons could make progress on Ozempic® or Wegovy® slow?
  • How is Ozempic® different from Wegovy® for weight?
  • How long does it take for weight to come off?
  • When should I talk with my prescriber?

Is it normal to not lose weight right away?

Weight loss on these medicines usually takes time. It rarely happens all at once.

In the STEP 1 trial of Wegovy® (brand of semaglutide), adults lost about 14.9% of body weight over 68 weeks. Placebo was about 2.4% (N=1,961). Most of that change built up slowly across the trial.

The gap between Wegovy® and placebo in STEP 1 was about 12.4 percentage points. That gap grew over many weeks, not in the first few.

Weight loss also tends to build on itself over time. The early weeks help set up the larger changes seen later in the trial.

Weight came off gradually and then began to flatten near the end of the trial. So a slow start can be part of the normal pattern.

People also respond differently to the same medicine. Two people at the same dose can see very different results, and that is expected.

In the STEP 1 trial of Wegovy®, weight came off gradually across 68 weeks, not all at once.

Not losing weight on a GLP-1 like Wegovy® or Ozempic®: what to check

Several everyday factors can affect how fast weight changes. None of these mean you have failed.

You may still be in the early dose steps, when weight change is often small.

Weight often comes off in waves, with plateaus in between.

Individual response varies, so two people can respond very differently.

Daily habits like eating patterns, activity, sleep, and stress all play a part.

Ozempic® is a type 2 diabetes brand, so its trials measured blood sugar, not weight.

Missing doses or a recent dose change can affect the pace of results.

A checklist like this is a starting point for a conversation, not a reason for blame. Your prescriber can look at the full picture with you.

Often more than one of these is true at the same time. That is normal, and it is worth reviewing them together with your prescriber.

Ozempic® and Wegovy®: same medicine, different jobs

Ozempic® and Wegovy® both contain semaglutide. The FDA approved them for different uses.

Ozempic® is approved for type 2 diabetes. Its main trials, like SUSTAIN 1, measured blood sugar (A1c), not weight.

In SUSTAIN 1, Ozempic® 1 mg lowered A1c by about 1.6%, while placebo lowered it by about 0.1% (N=388). That trial looked at blood sugar, not weight.

Wegovy® is the semaglutide brand approved for chronic weight management. Its STEP 1 trial measured body weight.

So if you take Ozempic®, weight change data come from the Wegovy® weight trials, not from Ozempic®'s diabetes trials.

Wegovy® reaches a higher maintenance dose than Ozempic®. That is one reason the two brands are studied for different goals.

Knowing which brand you take helps set fair expectations. Weight results come from the Wegovy® weight trials, and blood sugar results come from Ozempic®'s diabetes trials.

FeatureOzempic® (semaglutide)Wegovy® (semaglutide)
FDA-approved useType 2 diabetesChronic weight management
Once-weekly dose (per label)Up to 2 mgUp to 2.4 mg (maintenance)
What the main trial measuredSUSTAIN 1: A1c, not weightSTEP 1: body weight
Trial resultA1c about 1.6% lower at 1 mg (SUSTAIN 1, N=388)About 14.9% weight loss vs 2.4% placebo (STEP 1, 68 weeks, N=1,961)

Ozempic® and Wegovy® both use semaglutide, but only Wegovy® is FDA-approved for weight management. Figures come from each brand's named trial.

Ozempic® is approved for type 2 diabetes. Wegovy® is the semaglutide brand approved for weight management.

How weight comes off over time

The dose does not start at full strength. Your prescriber steps it up slowly over several weeks.

Here is the weight-management step-up schedule for Wegovy® from the FDA label. Your prescriber sets your own dose and timing.

1. Weeks 1 to 4: Wegovy® starts at 0.25 mg once weekly, a starting dose, not the target.

2. Weeks 5 to 8: Wegovy® 0.5 mg once weekly.

3. Weeks 9 to 12: Wegovy® 1 mg once weekly.

4. Weeks 13 to 16: Wegovy® 1.7 mg once weekly.

5. Week 17 and on: Wegovy® 2.4 mg once weekly, the recommended maintenance dose, or 1.7 mg.

The slow step-up is meant to help your body adjust. It can also ease stomach side effects while you get used to the medicine.

Reaching the maintenance dose can take about 16 to 17 weeks. So the early weeks may show smaller changes.

Ozempic® for type 2 diabetes also steps up slowly, from 0.25 mg to a maximum of 2 mg. Both brands are once-weekly injections under the skin.

Giving the medicine on the same day each week can help you keep a steady routine. A steady routine makes it easier to notice real changes over time.

If you miss a dose, do not double up on your own. Ask your prescriber or pharmacist how to get back on schedule.

Plateaus, habits, and staying on track

A plateau does not always mean the medicine stopped working. Weight often settles for a while before it moves again.

In the STEP 1 trial, the medicine was paired with a reduced-calorie eating plan and more activity. Those habits were part of how the results happened.

Side effects can also get in the way. Nausea, diarrhea, vomiting, and constipation are the most common with Wegovy® and Ozempic®. In Wegovy®'s trials, nausea was reported by about 44% of people, compared with about 16% on placebo.

Most of these effects tend to ease as the body adjusts. If they do not, your prescriber can talk through options with you.

Sleep and stress can also shape appetite and energy. Small, steady routines tend to help more than big changes all at once.

Tell your provider right away if nausea, vomiting, or diarrhea does not go away. Ongoing fluid loss can lead to dehydration and kidney problems.

A slower week or a plateau does not mean the medicine has stopped working.

One note on trial results: these results apply only to the FDA-approved branded product and do not transfer to compounded preparations. Compounded semaglutide is not FDA-approved and is not a generic of Wegovy® or Ozempic®. It is not evaluated by the FDA for safety, effectiveness, or quality.

Ways to track progress beyond the scale

The scale is only one measure. Weight can shift from day to day for reasons that have nothing to do with the medicine.

Looking at a trend over several weeks often tells you more than one weigh-in. In Wegovy®'s STEP 1 trial, the real story showed up over many months, not days.

You might also notice how your clothes fit or how you feel day to day. Share what you are seeing with your prescriber so you can plan together.

When to talk with your prescriber

Your prescriber is the best person to review your progress. They can look at your dose, your timing, and your health history.

Bring your questions and any side effects to your next visit. Do not change your dose on your own.

Staying in touch with your care team matters most. They can adjust the plan with you if progress is not what you hoped.

Ask what a realistic pace looks like for you. Ask when they would expect to see more change.

3. Wilding JPH, et al. STEP 1: once-weekly semaglutide in adults with overweight or obesity. NEJM. 2021. PMID 33567185. NCT03548935.

Frequently asked questions

Why am I not losing weight on my GLP-1 medicine?

Weight change can vary for many reasons. You may still be in the early dose steps, where change is often small. Weight also tends to come off in waves, with plateaus in between. Daily habits like eating, activity, and sleep matter too. Your prescriber can help you review what is going on and what to try next.

How long does it take to lose weight on Wegovy®?

In the STEP 1 trial of Wegovy® (brand of semaglutide), adults lost about 14.9% of body weight over 68 weeks. Placebo was about 2.4% (N=1,961). Weight came off slowly across the trial, not in the first few weeks. The dose is also stepped up over about 16 to 17 weeks, so early change is often small.

Does Ozempic® help with weight loss?

Ozempic® (brand of semaglutide) is FDA-approved for type 2 diabetes, not for weight management. Its main trials, such as SUSTAIN 1, measured blood sugar (A1c), not weight. Wegovy® is the semaglutide brand approved for chronic weight management, and its STEP 1 trial measured body weight. Your prescriber can explain which option fits your goals.

Is it normal to hit a weight loss plateau?

Yes, plateaus can be a normal part of the pattern. Weight often settles for a while before it moves again. A slower week does not always mean the medicine has stopped working. In the STEP 1 trial of Wegovy®, weight loss built up gradually and then began to flatten near the end. Share any concerns with your prescriber.

Could my daily habits affect my results?

They can play a part. In the STEP 1 trial, Wegovy® was paired with a reduced-calorie eating plan and more activity. Those habits were part of how the results happened. Eating patterns, movement, sleep, and stress can all affect the pace. This is not about blame, and small steady changes can add up over time.

What side effects might get in the way?

The most common side effects of Wegovy® and Ozempic® are nausea, diarrhea, vomiting, and constipation. These can make daily routines harder while your body adjusts. Tell your provider right away if nausea, vomiting, or diarrhea does not go away. Ongoing fluid loss can lead to dehydration and kidney problems, so do not wait it out alone.

Should I stop my medicine if the scale is not moving?

Do not stop or change your medicine on your own. A pause on the scale does not always mean it is not working. Weight often comes off in waves, and dose timing and daily habits can affect the pace. Your prescriber can review your plan and help you decide the next step together.

When should I talk with my prescriber about slow progress?

It is reasonable to reach out any time you feel stuck or worried. Your prescriber can review your dose, your timing, and your health history. They can also help set a realistic pace for you. Do not change your dose on your own. Bringing notes about your habits and side effects can make the visit more useful.

Keep reading

Want the bigger picture on how weight loss works and what to expect over time? See our weight loss guide for practical next steps.

Read more →

Important: This page is for education only and is not medical advice. Any medicines named here are available by prescription. Always talk to a licensed clinician about medicines, symptoms, or anything you are considering.

K
Written by

Kelly Miller

Kelly Miller is a health writer covering peptides, metabolic health, and the research shaping modern longevity and recovery. She came from science journalism at general-audience health publications, where she spent years translating dense clinical trials into stories regular people can actually use.

Comments